The number of stressful life events was predictive of first onset MD and AD.
In the multivariate regression model, VL was predictive of first attempt success with an odds ratio of 7.67 (95% CI 3.18 to 18.45).
DL, direct laryngoscope/laryngoscopy; PGY, post-graduate year; VL, video laryngoscope/laryngoscopy. In the multivariate regression model, VL was predictive of first attempt success with an odds ratio of 7.67 (95% CI 3.18 to 18.45).
A multivariate analysis revealed that three factors were predictive of first-line antibiotic treatment failure: age>60 (p = 0.011), thrombocytopenia <20,000/mm3 (p < 0.01) and WHO score >2 (p = 0.012).
Neuromuscular training focusing on restoring limb symmetry and improving knee function using sports-related movements may reduce aberrant movement patterns which are predictive of second injury risk [ 4, 12, 18, 19].
These results are in agreement with Lindqvist and colleagues who found the presence of the shared epitope to be predictive of radiographic progression during the first five years but not after five years of follow-up [ 18].
Two factors found to be predictive of stabilisation in patients receiving second-line paclitaxel: objective response to induction GIP (odds ratio 5.28, 95% confidence interval (CI) 2.01 13.87, P=0.001) and normal haemoglobin level (odds ratio 3.62, 95% CI 1.49 8.77, P=0.004).
Younger age at breast cancer diagnosis in the index case did not appear to be predictive of increased risk of a second neoplasm with relative risk of 1.12 for those aged <50 compared with 1.18 for those aged ⩽50 years at diagnosis.
The tidal flow index, tPTEF/ tE, measured during the first 3 months of life, has been shown to be predictive of subsequent wheezing in boys during the first 3 years [ 9, 10].
Patients with melanomas containing activating mutations in KIT have been reported to respond to imatinib therapy (Lutzky et al, 2008; Quintas-Cardama et al, 2008; Satzger et al, 2010); however, it remains uncertain whether mutations considered to be predictive of imatinib resistance can respond to second-generation KIT kinase inhibitors.
